Glial reaction in the hippocampal formation is highly correlated with aging in human brain
Neuroscience LettersPublished 1 October 1997
Jean‐Philippe David, Farida Ghozali, Catherine Fallet‐Bianco, A. Wattez, Stephanie Clisant Delaine, B. Boniface
Citations143
SJR quartileQ2
SJR score0.77
SNIP0.67
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
GFAP levels increased dramatically after the age of 65 years, and more especially in the hippocampal formation, and this glial reaction was observed in aged controls that do not show cognitive impairment and the neuropathological hallmarks of Alzheimer's disease.
Abstract
Glial fibrillary acidic protein (GFAP), a biochemical marker of astrocytes and glial reaction, was quantified by immunoblotting in different brain areas from 33 non-demented patients with a Mini Mental State Examination score above 26 and aged from 12 to 98 years. An increase of GFAP with age was first found in the hippocampus and then in the entorhinal cortex. In both regions, GFAP amounts were correlated with age (r = 0.768). In the isocortex, the increase of GFAP as a function of age was also significant (r = 0.672), but less than for the hippocampal region. GFAP levels increased dramatically after the age of 65 years, and more especially in the hippocampal formation. This glial reaction was observed in aged controls that do not show cognitive impairment and the neuropathological hallmarks of Alzheimer's disease.
Keywords
MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology
NatureCleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
251,640 Citations1970Ulrich K. Laemmli
Using an improved method of gel electrophoresis, many hitherto unknown proteins have been found in bacteriophage T4 and some of these have been identified with specific gene products.
NeurologyThe Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
4,979 Citations1991Suzanne S. Mirra, Albert Heyman +9 more
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a practical and standardized neuropathology protocol for the postmortem assessment of dementia and control subjects, which provides neuropathologic definitions of such terms as “definite Alzheimer's disease” (AD), “probable AD,” “possible AD” and “normal brain” to indicate levels of diagnostic certainty.
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
2,416 Citations2002Gerda G. Fillenbaum, Albert Heyman
Archives of General PsychiatryThe Mini-Mental State Examination
1,904 Citations1983Marshal F. Folstein
The Mini-Mental State Examination was designed as a clinical method for grading cognitive impairment and produces a score that can be used to follow the course of patients or as a case detection technique after cutoff scores are established.
Brain ResearchAn acidic protein isolated from fibrous astrocytes
1,221 Citations1971Lawrence F. Eng, Jean‐Jacques Vanderhaeghen +2 more
Proceedings of the National Academy of SciencesMolecular cloning and primary structure of human glial fibrillary acidic protein.
218 Citations1989Steven A. Reeves, Lee J. Helman +2 more
The predicted amino acid sequence of GFAP indicates that GFAP shares structural similarities--particularly in the central rod domain and to a lesser degree in the carboxyl-terminal domain--with other IF proteins found in nonepithelial cell types.
NeurologyGeneral and dramatic glial reaction in Alzheimer brains
207 Citations1990André Delacourte
The amount of GFAP was significantly higher than in brains from controls and other neurodegenerative disorders, even in brain regions usually free of AD lesions such as caudate nucleus, thalamus, cerebellum, or brainstem, but it might be a key element in the pathogenesis of AD.
Neurobiology of AgingAn immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex
154 Citations1987Lawrence A. Hansen, David M. Armstrong +1 more
The authors' data suggest that the increase occurs or accelerates significantly after age 70, but the case numbers preclude reaching such a conclusion with statistical confidence, however, when the patients are divided into those less than 70 and those older, fibrous astrocytes in the cellular layer are shown to be significantly increased in the latter group compared to the former.
Molecular Brain ResearchAD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease
150 Citations1996V. Buée-Scherer, O. Condamines +5 more
The properties of antibody AD2, which detects the hyperphosphorylated tau proteins forming paired helical filaments during Alzheimer's disease, are reported and it is shown that in autopsic brains, AD2 still represents a valuable tool to investigate neurofibrillary degeneration at the biochemical and immunocytochemical levels.
Neuroscience LettersNeurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes
142 Citations1993Constantin Bouras, Patrick R. Hof +1 more
It is proposed that these cases may represent the neuropathological correlate of the earliest stage of Alzheimer's disease that could antedate the appearance of clinical signs of cognitive decline and memory impairment.
Neurobiology of AgingIncreases of glial fibrillary acidic protein in the aging female mouse brain
137 Citations1995Steven G. Kohama, James R. Goss +2 more
Age-related increases of the astrocyte marker, glial fibrillary acidic protein (GFAP), were further resolved by in situ hybridization and immunocytochemistry in female C57BL/6J mice and imply the existence of a widespread stimulus for increased activity of astroCytes during aging.
Acta NeuropathologicaFibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type
88 Citations1983Gianluigi Mancardi, Boleslaw H. Liwnicz +1 more
In AD and SDAT there was a significant increase in the number of FA in the molecular layer as well as in the other layers of the cortex, and the GFAP positivity was most pronounced around small blood vessels.
Journal of NeurochemistryDistribution of Glial Fibrillary Acidic Protein in Gliosed Human White Matter
64 Citations1986Jia Newcombe, M. Nicola Woodroofe +1 more
In tissue autolysis studies, GFAP was stable in situ for periods well in excess of average CNS postmortem times, and was susceptible to proteolysis at acid but not at neutral pH in the presence of CNS homogenates.
Acta NeuropathologicaCorrelation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type
51 Citations1990Stéphane Flament, André Delacourte +3 more
These pathological forms of tau proteins are reliable markers of the presence of NFT and SP in the neocortex and may be used as a diagnostic tool.
Neuroscience LettersAlterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type
46 Citations1993G. Le Prince, P. Delaère +4 more
The GFAP mRNA levels were compared to the density of the senile plaques in postmortem brain samples of 8 cases, either non-demented or affected by senile dementia of the Alzheimer type, showing that in this area, astrocytes are altered at transcriptional or post-transcriptional levels, or both.
Neuroscience LettersPresence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects
44 Citations1992Patrick Vermersch, Bernard Frigard +3 more
It is demonstrated that the entorhinal cortex is the most vulnerable neuronal population in aging and that the biochemical dysfunctions observed in this area are typically of the 'Alzheimer-type'.